GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cardica, Inc. (CRDC) [hlAlert]

Rating:
Buy CRDC
down 95.55 %

Cardica, Inc. (CRDC) rated Buy by Merriman Curhan Ford

Posted on: Monday,  Sep 8, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Cardica, Inc. (NASDAQ: CRDC) on 09/08/2008, when the stock price was $7.88. Since
then, Cardica, Inc. has lost 95.56% as of 09/10/2015's recent price of $0.35.
If you would have followed this Merriman Curhan Ford's recommendation on CRDC, you would have lost 95.55% of your investment in 2558 days.

Cardica, Inc. designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft surgery. In these surgery procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, bypassing the narrowed or occluded portion of the artery that is impairing blood flow to the heart muscle. Our first two products, the C-Port Distal Anastomosis System, and the PAS-Port Proximal Anastomosis System, provide cardiovascular surgeons with easy-to-use automated systems to perform consistent, rapid and reliable connections, or anastomoses, of the vessels, which surgeons generally view as the most critical aspect of the bypass procedure.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/8/2008 8:25 AM Buy
None
7.88
as of 12/24/2008
1 Week up  10.20 %
1 Month down  -3.57 %
3 Months down  -3.57 %
1 YTD down  -22.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy